We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Horizon Discovery Takes Exclusive License for Transposon-based Gene Editing Technology Platform

Product News   Jul 05, 2017

 
Horizon Discovery Takes Exclusive License for Transposon-based Gene Editing Technology Platform
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Optimised Microplates for Affinity Binding Assays

Product News

Porvair Sciences new medium and high bind Krystal microplates set a new standard for uniform and reproducible capture of a wide range of biomolecules ready for affinity binding assays such as ELISA's.

READ MORE

Agilent Showcases Commitment to Sustainability at Analytica

Product News

Agilent Technologies Inc. (NYSE: A) today announced that their 1220, 1260 and 1290 Infinity II LC product families have received the My Green Lab accountability, consistency and transparency (ACT) certification.

READ MORE

Demystify Chromogenic Factor VIII Testing

Product News

For laboratories wishing to accurately quantify Factor VIII activity, there is now a ready-to-use Chromogenic Factor VIII Assay. The CRYOcheck™ assay is designed for ease of use and to minimize reagent waste. The assay is intended to identify Factor VIII deficiency and aid in the management of hemophilia A.

READ MORE

Like what you just read? You can find similar content on the communities below.

Diagnostics Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE